Beijing Magnesium Technology Co., Ltd

Scilia focuses on providing professional comprehensive research services and solutions for pharmaceutical innovation enterprises in the fields of cell and gene therapy (CGT). It has advanced automated CRISPR library screening platforms, automated gene vector preparation platforms, automated cell line screening platforms, high-throughput AI algorithms, and single-cell deep analysis bioinformatics platforms.

With Scilia's intelligent and automated platform, we can provide experimental services and related products in various disease fields. Mainly covering services such as gene vector construction and virus packaging, stable cell line construction and development, cell and gene function research, drug target validation, phenotype drug screening, and pathological detection and analysis; And products such as matrix glue, nucleic acid extraction and detection kits.

Scilia is committed to reducing R&D risks, shortening R&D cycles, saving R&D costs, accelerating the process of drug commercialization, and making the world a better and healthier place for customers.